Peripheral Angioplasty Market Valued at US$ 3.4 Billion in 2023, Poised to Reach US$ 7.2 Billion by 2033, Fueled by Rising Demand for Minimally Invasive PAD Treatments | Future Market Insights, Inc.

Peripheral arterial disease affects a considerable portion of the global population, particularly elderly individuals and those with risk factors like smoking, diabetes, and hypertension. The increasing prevalence of PAD is a key driver behind the growing demand for peripheral angioplasty procedures. This trend is further fueled by technological advancements and a rising preference for minimally invasive interventions.


NEWARK, Del, July 18, 2023 (GLOBE NEWSWIRE) -- A minimally invasive treatment called peripheral angioplasty is used to treat peripheral arterial disease (PAD), which is marked by the constriction or obstruction of blood vessels in the peripheral arteries, usually in the legs. A catheter with a little balloon tip is inserted into the troubled artery during the treatment. Inflation of the balloon widens or unblocks the artery, improving blood flow. The market for peripheral angioplasty has been expanding recently as a result of a number of causes, including an increase in the prevalence of PAD, technological developments, and a growing desire for minimally invasive procedures.

According to a recent market study by Future Market Insights, Global Peripheral Angioplasty Market was valued US$ 3.4 Billion in 2023, and it is anticipated to grow at a compound annual growth rate (CAGR) of 7.7%, reaching US$ 7.2 Billion by 2033.

Throughout the forecast period Peripheral artery disease affects a significant portion of the global population, especially elderly individuals and those with risk factors such as smoking, diabetes, and hypertension. The increasing prevalence of PAD is driving the demand for peripheral angioplasty procedures. The development of innovative devices and techniques has significantly improved the outcomes of peripheral angioplasty procedures. Advancements include the introduction of drug-coated balloons and drug-eluting stents, which help prevent restenosis (re-narrowing of the artery) and enhance long-term results.

The peripheral angioplasty market is also competitive, with several established and emerging players offering a range of devices and technologies. Intense competition may influence sales figures as companies strive to gain market share through product differentiation, pricing strategies, and marketing efforts.

Download Our Sample Report for Key Insights into the US$ 7.2 Billion Peripheral Angioplasty Market! https://www.futuremarketinsights.com/reports/sample/rep-gb-17632

Key Takeaways from the Peripheral Angioplasty Market:

  • The peripheral angioplasty industry in the United States is predicted to reach US$ 2.3 billion by 2033, increasing at a 6.8% CAGR.
  • The peripheral angioplasty industry in the United Kingdom is estimated to reach a market share of US$ 229.3 million, expanding at a CAGR of 4.2% by 2033.
  • During the forecast period, the peripheral angioplasty industry in China is expected to reach a market share of US$ 732.1 million, securing an 13.0% CAGR.
  • The peripheral angioplasty industry in Japan is predicted to reach US$ 448.8 million by 2033, increasing at a 9.0% CAGR.
  • South Korea's peripheral angioplasty industry is predicted to achieve a market share of US$ 143.7 million, rising at an 8.7% CAGR during the forecast period.
  • With a CAGR of 5.2% from 2023 to 2033, the balloon catheters segment is expected to dominate the peripheral angioplasty industry.
  • With a CAGR of 6.3% from 2023 to 2033, the hospital is expected to dominate the peripheral angioplasty industry.

To save Up To 30%, you can tailor your report by choosing particular countries or regions. https://www.futuremarketinsights.com/customization-available/rep-gb-17632

Peripheral Angioplasty Manufacturers and Their Effective Marketing Strategies

The peripheral angioplasty sector is a very competitive one, with many firms fighting for market share. Several significant participants in this industry comprise

  1. Boston Scientific Corporation
  2. Medtronic
  3. Abbott Laboratories
  4. Terumo Corporation
  5. Johnson & Johnson
  6. Cook Medical
  7. B. Braun Melsungen AG
  8. Edwards Lifesciences Corporation
  9. Becton, Dickinson, and Company
  10. MicroPort Scientific Corporation
  11. Teleflex Incorporated
  12. W. L. Gore & Associates
  13. Biotronik SE & Co. KG
  14. AngioDynamics, Inc.

The main corporations are investing extensively in research and development efforts to develop inventive and creative products with improved reliability, efficacy, and cost.

Tactical alliances and partnerships with other companies are becoming more common in the industry, allowing parties to leverage one another's strengths and expand their market influence.

Leading firms use consolidation and mergers to strengthen their market position and gain entry into new markets. The sector is expanding significantly in developing economies, particularly in India and China.

To boost their presence in these regions, major companies are expanding their distribution networks and building regional manufacturing sites. They are also concentrating on offering cost-effective solutions to customers in these markets in order to get a competitive advantage.

Key Companies in the Peripheral Angioplasty Industry along with Their Market Share Analysis. Purchase Now at Discounted Pricing! https://www.futuremarketinsights.com/checkout/17632

Segmentation Analysis of the Peripheral Angioplasty Market:

By Product:

  • Balloon Catheters
  • Stents
  • Guidewires

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catheterization Centers

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East & Africa

Consult our Analyst to discuss the report scope and tailor your requirements: https://www.futuremarketinsights.com/ask-question/rep-gb-17632

Explore FMI’s Extensive ongoing Coverage in Healthcare Domain:

Continuous Peripheral Nerve Block Catheter Market Size: The global continuous peripheral nerve block catheter market is estimated to be valued at US$ 742.7 Mn by 2027 end, due to increasing adoption of continuous peripheral nerve block catheters especially in hospitals

Temporary Pacing Leads Market Share: The market is anticipated to reach from US$ 322.5 million in 2023 to US$ 587.2 million by 2033, with a growing CAGR of 6.2% from 2023 to 2033.

Peripheral Embolization Device Market Growth: Embolization is a process through which an embolus is placed into the blood vessel to block the blood flow to a particular area of the body. The embolus is usually a blood clot formed due to the clotting of blood cells.

Peripheral Vascular Stents Market Trend: According to the latest industry analysis by FMI, the global Peripheral Vascular Stents Market reached a valuation of around US$ 3.5 Bn in 2021, and is expected to attain a net worth of US$ 5.3 Bn by 2028, expanding at a CAGR of 6% over the assessment period of 2022 to 2028.

Peripheral Vascular Devices Market Forecast: The global peripheral vascular devices market is expected to enjoy a valuation of US$ 4.7 Billion by the end of the year 2022, and further expand at a CAGR of 6.6% to reach a valuation of US$ 8.9 Billion by the year 2032.

Chronic Wound Care Market Analysis: The global chronic wound care market is expected to reach US$ 15.98 Billion in 2023 and is projected to exhibit a CAGR of 7% from 2022 to 2032.

Antimicrobial Wound Care Dressings Market Sales: From 2023 to 2033, the global antimicrobial wound care dressings market is estimated to be worth US$ 1.38 billion, with a CAGR of 6.4%. The global antimicrobial wound dressings market is expected to reach US$ 2.57 billion by 2033.

Systemic Sclerosis Treatment Market Outlook: The global revenue from the systemic sclerosis treatment market stands at US$ 928.1 Million in 2022, with the global market expected to grow at a CAGR of 7.9% to reach a valuation of US$ 2.2 Billion by the end of 2033.

Osteotomy Plates Market Volume: The osteotomy plates market is forecasted to be appraised at US$ 615.5 million by 2033, up from US$ 375.5 million in 2023, advancing at a CAGR of 5.1% during the forecast period.

Osteonecrosis Treatment Market Application: The osteonecrosis treatment market size is projected to be valued at US$ 268.2 million in 2023 and is expected to rise to US$ 434.0 million by 2033.

About Future Market Insights (FMI):

Future Market Insights, Inc. (ESOMAR certified, Stevie Award - recipient market research organization, and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel, and End Use over the next 10 years.

Contact Us:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
LinkedInTwitterBlogs | YouTube
For Sales Enquiries: sales@futuremarketinsights.com